Table 2.

Cox regression analyses for the composite endpoint of cardiac death, CCF, and AMI

PredictorUnivariate AnalysesMultivariate Analyses
HR (95% CI)P ValueHR (95% CI)P Value
eGFR (ml/min per 1.73 m2)1.20 (1.08 to 1.33)0.0011.13 (1.01 to 1.26)0.04
Hypertensiona3.04 (1.50 to 6.16)0.0022.18 (1.05 to 4.54)0.04
LAVI (ml/m2)1.48 (1.15 to 1.90)0.0031.35 (1.02 to 1.77)0.04
Diabetes mellitus2.21 (1.21 to 4.03)0.011.83 (0.10 to 3.38)0.05
LVEF (%)0.96 (0.93 to 0.99)0.01
LVMI (g/m2)1.47 (1.20 to 1.79)<0.001
Age (yr)1.04 (1.01 to 1.06)0.001
β-Blocker1.91 (1.03 to 3.55)0.04
ACEI/ARB1.87 (1.01 to 3.47)<0.05
Aspirin1.79 (0.99 to 3.26)0.06
Men1.23 (0.67 to 2.29)0.51
BSA (m2)0.83 (0.22 to 3.13)0.78
Atrial fraction (%)1.00 (0.98 to 1.02)0.99
  • CCF, congestive cardiac failure; AMI, acute myocardial infarction; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; HR, hazard ratio; 95% CI, 95% confidence interval.

  • a Arterial pressure>130/85 mmHg or normotensive patient with a history of hypertension on antihypertensive treatment.